Title of article
Symptom Evaluation in Pediatric Oncology Outpatient Setting; A Cross-Sectional Study
Author/Authors
Kargar, Mona Research Center for Rational Use of Drugs - Tehran University of Medical Sciences, Tehran, Iran , Motaghedi, Rozita School of pharmacy - International Campus - Tehran University of Medical Sciences, Tehran, Iran , Mansouri, Ava Research Center for Rational Use of Drugs - Tehran University of Medical Sciences, Tehran, Iran , hajibabaie, Molouk Research Center for Rational Use of Drugs - Tehran University of Medical Sciences, Tehran, Iran , Heidari, Kazem Research Center for Rational Use of Drugs - Tehran University of Medical Sciences, Tehran, Iran , Rashidian, Arash Department of Global Health and Public Policy - School of Public Health - Tehran University of Medical Sciences, Tehran, Iran , Ansari, Shahla Department of Hematology and Oncology - Ali Asghar Children Hospital - Iran University of Medical Sciences, Tehran, Iran , Gholami, Kheirollah Research Center for Rational Use of Drugs - Tehran University of Medical Sciences, Tehran, Iran
Pages
14
From page
27
To page
40
Abstract
Detection and management of cancer-related symptoms is a key component in children’s quality of life. We evaluate symptoms and their severity in Iranian pediatric oncology outpatients using Therapy-Related Symptom Checklist for Children (TRSC-C). This was a cross-sectional study conducted in two outpatient pediatric oncology settings. We included all patients aged between 5-17 years. The validated and reliable Persian translated version of TRSC-C was used to study the symptoms. Overall 1425 symptoms were documented from 162 patients (mean age 8.6 ±3.2, acute lymphoblastic leukemia: 76.5%). In 96.3% of patients at least one symptom was present. Twenty (12.34%) patients experienced at least 15 events. Irritable, loss of appetite, cough, pain and hair loss were the top 5 frequent symptoms. The highest mean severity scores were also belonged to irritable, loss of appetite, and hair loss. We found no significant difference between gender, age group or time of the last chemotherapy with mean total severity scores or total number of symptoms (P>0.05). In conclusion, TRSC-C is an appropriate symptom assessment checklist for our settings and it would give us the ability to track symptoms and designate clinical interventions based on the frequent and severe identified symptoms.
Keywords
TRSC-C , Therapy-Related Symptom Checklist for Children , Symptom severity , Symptom frequency , Pediatric oncology
Journal title
Iranian Journal of Pharmaceutical Sciences (IJPS)
Serial Year
2019
Record number
2499665
Link To Document